Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Sebastian J. Schober, Irene von Luettichau, Angela Wawer, Maximilian Steinhauser, Christoph Salat, Wolfgang Schwinger, Marek Ussowicz, Petar Antunovic, Luca Castagna, Hans-Jochem Kolb, Stefan EG Burdach, Uwe Thiel
Published Apr 27, 2018 · Vol. 9, No. 32 · pp. 22741-22748
Bruno Christian Köhler, Benjamin Goeppert, Nina Waldburger, Kai Schlamp, Peter Sauer, Dirk Jäger, Karl Heinz Weiss, Stephan Macher-Göppinger, Henning Schulze-Bergkamen, Peter Schirmacher, Christoph Springfeld
Published Apr 24, 2018 · Vol. 9, No. 31 · pp. 22230-22235
Anne Heisig, Jan Sörensen, Stefanie-Yvonne Zimmermann, Stefan Schöning, Dirk Schwabe, Hans-Michael Kvasnicka, Raphaela Schwentner, Caroline Hutter, Thomas Lehrnbecher
Published Apr 24, 2018 · Vol. 9, No. 31 · pp. 22236-22240
Hussein F. Aqbi, Liliya Tyutyunyk-Massey, Rebecca C. Keim, Savannah E. Butler, Theresa Thekkudan, Supriya Joshi, Timothy M. Smith, Dipankar Bandyopadhyay, Michael O. Idowu, Harry D. Bear, Kyle K. Payne, David A. Gewirtz, Masoud H. Manjili
Published Apr 24, 2018 · Vol. 9, No. 31 · pp. 22113-22122